[Nerve flow dynamics in the pathogenesis of diabetic neuropathy].
Ueda
Hiroo
H
Diabetes Center, Kobe Mahoshi Hospital.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D000818:Animals; D002196:Capillaries / Q000503:physiopathology; D002199:Capillary Permeability; D003929:Diabetic Neuropathies / Q000209:etiology* / Q000628:therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D015316:Genetic Therapy; D017228:Hepatocyte Growth Factor / Q000235:genetics; D006801:Humans; D007511:Ischemia; D018384:Oxidative Stress; D010525:Peripheral Nerves / Q000098:blood supply*; D012039:Regional Blood Flow; D015427:Reperfusion Injury / Q000209:etiology; D012236:Rhodanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D053778:Thiazolidines; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics
D004791:Enzyme Inhibitors; D053778:Thiazolidines; D042461:Vascular Endothelial Growth Factor A; C038131:epalrestat; D017228:Hepatocyte Growth Factor; D012236:Rhodanine; D000449:Aldehyde Reductase